The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Treating Pediatric Patients Using Dexmedetomidine - EP2766014

The patent EP2766014 was granted to Hospira on Jul 18, 2018. The application was filed on Sep 27, 2012 under application number EP12840033A. The patent is currently recorded with a legal status of "Revoked".

EP2766014

HOSPIRA
Application Number
EP12840033A
Filing Date
Sep 27, 2012
Status
Revoked
Jan 22, 2021
Publication Date
Jul 18, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
FRESENIUS KABI DEUTSCHLANDApr 16, 2019FRESENIUS KABI DEUTSCHLAND -

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS4407957
DESCRIPTIONUS5520639
DESCRIPTIONUS5654007
DESCRIPTIONUS5704911
DESCRIPTIONUS5780014
DESCRIPTIONUS5798113
DESCRIPTIONUS5814607
DESCRIPTIONUS5846233
DESCRIPTIONUS5879327
OPPOSITIONWO2013055528
SEARCHUS6716867

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents